Elevated CRP levels in the early stages of COVID-19 have been associated with more severe disease and greater mortality [60,61,62], leading to recommendation for its use as a prognostic indicator when evaluating risk in patients hospitalized for COVID-19. This evidence concerns the gene CRP and COVID-19.